Realm
Bioregulators
32 Cytomax / Cytogen peptide bioregulators — tissue targets, protocol patterns, and aftereffect windows.
Search and filters
Results
Showing 32 of 32
Suprefort
Cytogen · PancragenAla-Glu-Asp-Gly
Target: Pancreas
Aftereffect window: Aftereffect/durability window: 6–12 months reported for Cytomax oral cycles.; Aftereffect/durability window: 1.5–2 months reported for Cytogen injectable cycles.
Organ-specific peptide complex; link to Protocol_Templates where applicable. | Bioregulator brochure / Cheat Sheet / Complete Guide
Stamakort
Target: Gastric mucosa
Aftereffect window: Aftereffect/durability window: 6–12 months reported for Cytomax oral cycles.;
Organ-specific peptide complex; link to Protocol_Templates where applicable. | Bioregulator brochure / Cheat Sheet / Complete Guide
Visoluten
Cytogen · VilonLys-Glu
Target: Retina/eye tissues
Aftereffect window: Aftereffect/durability window: 6–12 months reported for Cytomax oral cycles.; Aftereffect/durability window: 1.5–2 months reported for Cytogen injectable cycles.
Organ-specific peptide complex; link to Protocol_Templates where applicable. | Bioregulator brochure / Cheat Sheet / Complete Guide
Chitomur
Cytogen · Vesilute
Target: Bladder
Aftereffect window: Aftereffect/durability window: 6–12 months reported for Cytomax oral cycles.; Aftereffect/durability window: 1.5–2 months reported for Cytogen injectable cycles.
Organ-specific peptide complex; link to Protocol_Templates where applicable. | Bioregulator brochure / Cheat Sheet / Complete Guide
Testoluten
Cytogen · Testagen
Target: Testes
Aftereffect window: Aftereffect/durability window: 6–12 months reported for Cytomax oral cycles.; Aftereffect/durability window: 1.5–2 months reported for Cytogen injectable cycles.
Organ-specific peptide complex; link to Protocol_Templates where applicable. | Bioregulator brochure / Cheat Sheet / Complete Guide
Chelohart
Cytogen · CardiogenAla-Glu-Asp-Arg
Target: Heart muscle
Aftereffect window: Aftereffect/durability window: 6–12 months reported for Cytomax oral cycles.; Aftereffect/durability window: 1.5–2 months reported for Cytogen injectable cycles.
Organ-specific peptide complex; link to Protocol_Templates where applicable. | Bioregulator brochure / Cheat Sheet / Complete Guide
Zhenoluten
Target: Ovaries
Aftereffect window: Aftereffect/durability window: 6–12 months reported for Cytomax oral cycles.;
Organ-specific peptide complex; link to Protocol_Templates where applicable. | Bioregulator brochure / Cheat Sheet / Complete Guide
Libidon
Cytogen · Prostamax
Target: Prostate
Aftereffect window: Aftereffect/durability window: 6–12 months reported for Cytomax oral cycles.; Aftereffect/durability window: 1.5–2 months reported for Cytogen injectable cycles.
Organ-specific peptide complex; link to Protocol_Templates where applicable. | Bioregulator brochure / Cheat Sheet / Complete Guide
Glandokort
Target: Adrenal glands
Aftereffect window: Aftereffect/durability window: 6–12 months reported for Cytomax oral cycles.;
Organ-specific peptide complex; link to Protocol_Templates where applicable. | Bioregulator brochure / Cheat Sheet / Complete Guide
Gotratix
Target: Muscle
Aftereffect window: Aftereffect/durability window: 6–12 months reported for Cytomax oral cycles.;
Organ-specific peptide complex; link to Protocol_Templates where applicable. | Bioregulator brochure / Cheat Sheet / Complete Guide
Taxorest
Cytogen · ChonlutenGlu-Asp-Gly
Target: Bronchial mucosa
Aftereffect window: Aftereffect/durability window: 6–12 months reported for Cytomax oral cycles.; Aftereffect/durability window: 1.5–2 months reported for Cytogen injectable cycles.
Organ-specific peptide complex; link to Protocol_Templates where applicable. | Bioregulator brochure / Cheat Sheet / Complete Guide
Thyreogen
Target: Thyroid
Aftereffect window: Aftereffect/durability window: 6–12 months reported for Cytomax oral cycles.;
Organ-specific peptide complex; link to Protocol_Templates where applicable. | Bioregulator brochure / Cheat Sheet / Complete Guide
Bonomarlot
Target: Bone marrow
Aftereffect window: Aftereffect/durability window: 6–12 months reported for Cytomax oral cycles.;
Organ-specific peptide complex; link to Protocol_Templates where applicable. | Bioregulator brochure / Cheat Sheet / Complete Guide
Bonothyrk
Target: Parathyroid
Aftereffect window: Aftereffect/durability window: 6–12 months reported for Cytomax oral cycles.;
Organ-specific peptide complex; link to Protocol_Templates where applicable. | Bioregulator brochure / Cheat Sheet / Complete Guide
Ventfort
Cytogen · VesugenLys-Glu-Asp
Target: Blood vessels
Aftereffect window: Aftereffect/durability window: 6–12 months reported for Cytomax oral cycles.; Aftereffect/durability window: 1.5–2 months reported for Cytogen injectable cycles.
Organ-specific peptide complex; link to Protocol_Templates where applicable. | Bioregulator brochure / Cheat Sheet / Complete Guide
Sigumir
Cytogen · CartalaxAla-Glu-Asp
Target: Cartilage and joints
Aftereffect window: Aftereffect/durability window: 6–12 months reported for Cytomax oral cycles.; Aftereffect/durability window: 1.5–2 months reported for Cytogen injectable cycles.
Organ-specific peptide complex; link to Protocol_Templates where applicable. | Bioregulator brochure / Cheat Sheet / Complete Guide
Cerluten
Cytogen · PinealonGlu-Asp-Arg
Target: Brain
Aftereffect window: Aftereffect/durability window: 6–12 months reported for Cytomax oral cycles.; Aftereffect/durability window: 1.5–2 months reported for Cytogen injectable cycles.
Organ-specific peptide complex; link to Protocol_Templates where applicable. | Bioregulator brochure / Cheat Sheet / Complete Guide
Vladonix
Cytogen · CrystagenLys-Glu-Asp
Target: Thymus
Aftereffect window: Aftereffect/durability window: 6–12 months reported for Cytomax oral cycles.; Aftereffect/durability window: 1.5–2 months reported for Cytogen injectable cycles.
Organ-specific peptide complex; link to Protocol_Templates where applicable. | Bioregulator brochure / Cheat Sheet / Complete Guide
Svetinorm
Cytogen · Livagen
Target: Liver
Aftereffect window: Aftereffect/durability window: 6–12 months reported for Cytomax oral cycles.; Aftereffect/durability window: 1.5–2 months reported for Cytogen injectable cycles.
Organ-specific peptide complex; link to Protocol_Templates where applicable. | Bioregulator brochure / Cheat Sheet / Complete Guide
Endoluten
Cytogen · EpitalonAla-Glu-Asp-Gly
Target: Pineal gland
Aftereffect window: Aftereffect/durability window: 6–12 months reported for Cytomax oral cycles.; Aftereffect/durability window: 1.5–2 months reported for Cytogen injectable cycles.
Organ-specific peptide complex; link to Protocol_Templates where applicable. | Bioregulator brochure / Cheat Sheet / Complete Guide
Pielotax
Target: Kidney
Aftereffect window: Aftereffect/durability window: 6–12 months reported for Cytomax oral cycles.;
Organ-specific peptide complex; link to Protocol_Templates where applicable. | Bioregulator brochure / Cheat Sheet / Complete Guide
Normoftal
Target: Eye tissues
Aftereffect window: Aftereffect/durability window: 6–12 months reported for Cytomax oral cycles.;
Organ-specific peptide complex; link to Protocol_Templates where applicable. | Bioregulator brochure / Cheat Sheet / Complete Guide
Cytogen · BronchogenAla-Leu-Asp-Glu
Target: Bronchi / airways
Aftereffect window: Aftereffect/durability window: 1.5–2 months reported for Cytogen injectable cycles.
Cytogen-only or legacy/synthetic peptide entry. | Khavinson guide / Bioregulator protocol files
Cytogen · CortagenAla-Glu-Asp-Pro
Target: Brain
Aftereffect window: Aftereffect/durability window: 1.5–2 months reported for Cytogen injectable cycles.
Cytogen-only or legacy/synthetic peptide entry. | Khavinson guide / Bioregulator protocol files
Cytogen · Cortexin
Target: Brain cortex
Aftereffect window: Aftereffect/durability window: 1.5–2 months reported for Cytogen injectable cycles.
Cytogen-only or legacy/synthetic peptide entry. | Khavinson guide / Bioregulator protocol files
Cytogen · Epithalamin
Target: Pineal gland
Aftereffect window: Aftereffect/durability window: 1.5–2 months reported for Cytogen injectable cycles.
Cytogen-only or legacy/synthetic peptide entry. | Khavinson guide / Bioregulator protocol files
Cytogen · Ovagen
Target: Liver / GI tract
Aftereffect window: Aftereffect/durability window: 1.5–2 months reported for Cytogen injectable cycles.
Cytogen-only or legacy/synthetic peptide entry. | Khavinson guide / Bioregulator protocol files
Cytogen · Prostatilen
Target: Prostate
Aftereffect window: Aftereffect/durability window: 1.5–2 months reported for Cytogen injectable cycles.
Cytogen-only or legacy/synthetic peptide entry. | Khavinson guide / Bioregulator protocol files
Cytogen · ThymagenGlu-Trp
Target: Thymus
Aftereffect window: Aftereffect/durability window: 1.5–2 months reported for Cytogen injectable cycles.
Cytogen-only or legacy/synthetic peptide entry. | Khavinson guide / Bioregulator protocol files
Retinalamin
Target: Retina
Aftereffect window: Aftereffect/durability window: 6–12 months reported for Cytomax oral cycles.;
Organ-specific peptide complex; link to Protocol_Templates where applicable. | Bioregulator brochure / Cheat Sheet / Complete Guide
Cytogen · ThymogenGlu-Trp
Target: Thymus
Aftereffect window: Aftereffect/durability window: 1.5–2 months reported for Cytogen injectable cycles.
Cytogen-only or legacy/synthetic peptide entry. | Khavinson guide / Bioregulator protocol files
Pinalex
Target: Eye/vision
Aftereffect window: Aftereffect/durability window: 6–12 months reported for Cytomax oral cycles.;
Organ-specific peptide complex; link to Protocol_Templates where applicable. | Bioregulator brochure / Cheat Sheet / Complete Guide